These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

965 related articles for article (PubMed ID: 27276234)

  • 1. Intensive Blood-Pressure Lowering in Patients with Acute Cerebral Hemorrhage.
    Qureshi AI; Palesch YY; Barsan WG; Hanley DF; Hsu CY; Martin RL; Moy CS; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Wang Y; Yamamoto H; Yoon BW;
    N Engl J Med; 2016 Sep; 375(11):1033-43. PubMed ID: 27276234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intensive Blood Pressure Lowering in Patients with Moderate to Severe Grade Acute Cerebral Hemorrhage: Post Hoc Analysis of Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-2 Trial.
    Qureshi AI; Foster LD; Lobanova I; Huang W; Suarez JI
    Cerebrovasc Dis; 2020; 49(3):244-252. PubMed ID: 32585668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid blood-pressure lowering in patients with acute intracerebral hemorrhage.
    Anderson CS; Heeley E; Huang Y; Wang J; Stapf C; Delcourt C; Lindley R; Robinson T; Lavados P; Neal B; Hata J; Arima H; Parsons M; Li Y; Wang J; Heritier S; Li Q; Woodward M; Simes RJ; Davis SM; Chalmers J;
    N Engl J Med; 2013 Jun; 368(25):2355-65. PubMed ID: 23713578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale.
    Qureshi AI; Palesch YY
    Neurocrit Care; 2011 Dec; 15(3):559-76. PubMed ID: 21626077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensive lowering of blood pressure in the acute phase of intracranial haemorrhage.
    Bozzano V; Carandini T;
    Intern Emerg Med; 2017 Apr; 12(3):379-380. PubMed ID: 28280979
    [No Abstract]   [Full Text] [Related]  

  • 6. Outcomes of Intensive Systolic Blood Pressure Reduction in Patients With Intracerebral Hemorrhage and Excessively High Initial Systolic Blood Pressure: Post Hoc Analysis of a Randomized Clinical Trial.
    Qureshi AI; Huang W; Lobanova I; Barsan WG; Hanley DF; Hsu CY; Lin CL; Silbergleit R; Steiner T; Suarez JI; Toyoda K; Yamamoto H;
    JAMA Neurol; 2020 Nov; 77(11):1355-1365. PubMed ID: 32897310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH)-II at Japan site: study design and advance construction of domestic research network].
    Sato S; Yamamoto H; Qureshi AI; Palesch YY; Toyoda K;
    Rinsho Shinkeigaku; 2012; 52(9):642-50. PubMed ID: 22989898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal Trajectory of Systolic Blood Pressure and Outcomes in Acute Intracerebral Hemorrhage: ATACH-2 Trial Cohort.
    Tanaka K; Koga M; Fukuda-Doi M; Qureshi AI; Yamamoto H; Miwa K; Ihara M; Toyoda K;
    Stroke; 2022 Jun; 53(6):1854-1862. PubMed ID: 35400202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of hypertensive emergencies in acute brain disease: evaluation of the treatment effects of intravenous nicardipine on cerebral oxygenation.
    Narotam PK; Puri V; Roberts JM; Taylon C; Vora Y; Nathoo N
    J Neurosurg; 2008 Dec; 109(6):1065-74. PubMed ID: 19035721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute hypertension in patients with intracerebral hemorrhage using American Heart Association guidelines.
    Qureshi AI; Harris-Lane P; Kirmani JF; Ahmed S; Jacob M; Zada Y; Divani AA
    Crit Care Med; 2006 Jul; 34(7):1975-80. PubMed ID: 16641615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnitude of blood pressure reduction and clinical outcomes in acute intracerebral hemorrhage: intensive blood pressure reduction in acute cerebral hemorrhage trial study.
    Wang X; Arima H; Heeley E; Delcourt C; Huang Y; Wang J; Stapf C; Robinson T; Woodward M; Chalmers J; Anderson CS;
    Hypertension; 2015 May; 65(5):1026-32. PubMed ID: 25801872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Robinson TG; Chalmers J; Suarez JI; Qureshi AI; Palesch YY; Anderson CS
    Lancet Neurol; 2019 Sep; 18(9):857-864. PubMed ID: 31397290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study.
    Qureshi AI; Palesch YY; Martin R; Novitzke J; Cruz-Flores S; Ehtisham A; Ezzeddine MA; Goldstein JN; Hussein HM; Suri MF; Tariq N;
    Arch Neurol; 2010 May; 67(5):570-6. PubMed ID: 20457956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood Pressure-Attained Analysis of ATACH 2 Trial.
    Qureshi AI; Palesch YY; Foster LD; Barsan WG; Goldstein JN; Hanley DF; Hsu CY; Moy CS; Qureshi MH; Silbergleit R; Suarez JI; Toyoda K; Yamamoto H;
    Stroke; 2018 Jun; 49(6):1412-1418. PubMed ID: 29789395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive Blood Pressure Reduction and Spot Sign in Intracerebral Hemorrhage: A Secondary Analysis of a Randomized Clinical Trial.
    Morotti A; Brouwers HB; Romero JM; Jessel MJ; Vashkevich A; Schwab K; Afzal MR; Cassarly C; Greenberg SM; Martin RH; Qureshi AI; Rosand J; Goldstein JN;
    JAMA Neurol; 2017 Aug; 74(8):950-960. PubMed ID: 28628707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mannitol and Outcome in Intracerebral Hemorrhage: Propensity Score and Multivariable Intensive Blood Pressure Reduction in Acute Cerebral Hemorrhage Trial 2 Results.
    Wang X; Arima H; Yang J; Zhang S; Wu G; Woodward M; Muñoz-Venturelli P; Lavados PM; Stapf C; Robinson T; Heeley E; Delcourt C; Lindley RI; Parsons M; Chalmers J; Anderson CS;
    Stroke; 2015 Oct; 46(10):2762-7. PubMed ID: 26265125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical analysis plan for pooled individual patient data from two landmark randomized trials (INTERACT2 and ATACH-II) of intensive blood pressure lowering treatment in acute intracerebral hemorrhage.
    Moullaali TJ; Wang X; Martin RH; Shipes VB; Qureshi AI; Anderson CS; Palesch YY
    Int J Stroke; 2019 Apr; 14(3):321-328. PubMed ID: 30418098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review.
    Toyoda K; Yoshimura S; Fukuda-Doi M; Qureshi AI; Martin RH; Palesch YY; Ihara M; Suarez JI; Okada Y; Hsu CY; Itabashi R; Wang Y; Yamagami H; Steiner T; Sakai N; Yoon BW; Inoue M; Minematsu K; Yamamoto H; Koga M;
    Int J Stroke; 2022 Jun; 17(5):494-505. PubMed ID: 34542358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intensive Blood Pressure Lowering and DWI Lesions in Intracerebral Hemorrhage: Exploratory Analysis of the ATACH-2 Randomized Trial.
    Shoamanesh A; Cassarly C; Morotti A; Romero JM; Oliveira-Filho J; Schlunk F; Jessel M; Butcher K; Gioia L; Ayres A; Vashkevich A; Schwab K; Afzal MR; Martin RH; Qureshi AI; Greenberg SM; Rosand J; Goldstein JN;
    Neurocrit Care; 2022 Feb; 36(1):71-81. PubMed ID: 34292474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systolic blood pressure lowering to 160 mmHg or less using nicardipine in acute intracerebral hemorrhage: a prospective, multicenter, observational study (the Stroke Acute Management with Urgent Risk-factor Assessment and Improvement-Intracerebral Hemorrhage study).
    Koga M; Toyoda K; Yamagami H; Okuda S; Okada Y; Kimura K; Shiokawa Y; Nakagawara J; Furui E; Hasegawa Y; Kario K; Osaki M; Miyagi T; Endo K; Nagatsuka K; Minematsu K;
    J Hypertens; 2012 Dec; 30(12):2357-64. PubMed ID: 22990355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.